prof. dr. Philippe Gevaert
- ORCID iD
- 0000-0002-1629-8468
Show
Sort by
-
- Journal Article
- A2
- open access
EUFOREA summit in Brussels 2023 : inspiring the future of allergy & respiratory care
-
- Journal Article
- A2
- open access
Chronic rhinosinusitis : matching the extent of surgery with pathology or does the extent of surgery matter?
-
- Journal Article
- A1
- open access
The unified airway hypothesis : evidence from specific intervention with anti–IL-5 biologic therapy
-
The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
The indispensable nasal decongestant : patients' views and perspectives on nasal decongestant overuse
-
- Journal Article
- A2
- open access
Proposal for structured histopathology of nasal secretions for endotyping chronic rhinosinusitis : an exploratory study
-
- Journal Article
- A1
- open access
Respiratory infections and anti-infective medication use from phase 3 dupilumab respiratory studies
-
- Journal Article
- A1
- open access
The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps
-
Reboot surgery for chronic rhinosinusitis with nasal polyposis : recurrence and smell kinetics
-
- Journal Article
- A1
- open access
The role of IgE in upper and lower airway disease : more than just allergy!
-
- Journal Article
- A1
- open access
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
-
Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER)
-
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps
-
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps : a randomized, placebo-controlled trial
-
COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies
-
- Journal Article
- A1
- open access
Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study
-
- Journal Article
- A2
- open access
Pathophysiological and clinical aspects of chronic rhinosinusitis : current concepts
-
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps : results from the SINUS-24 and SINUS-52 phase 3 trials
(2021) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. In American Journal of Respiratory and Critical Care Medicine 203(9S). p.A1341-A1341 -
- Journal Article
- A1
- open access
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
-
- Journal Article
- A1
- open access
Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP
-
Mepolizumab for chronic rhinosinusitis with nasal polyps
-
Mepolizumab improves health related quality of life for patients with chronic rhinosinusitis with nasal polyps : data from the SYNAPSE study
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic : an EAACI position paper
-
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial
-
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps : a systematic review for the EAACI guidelines
-
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics : definitions and management
-
Surgery in nasal polyp patients : outcome after a minimum observation of 10 years
-
Omalizumab or dupilumab for chronic rhinosinusitis with nasal polyposis Reply
-
ARIA digital anamorphosis : digital transformation of health and care in airway diseases from research to practice
-
Personalized medicine for allergy treatment : allergen immunotherapy still a unique and unmatched model
-
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis : an EAACI position paper (vol 10, 1, 2020)
-
The role of mobile health technologies in allergy care : an EAACI position paper
-
- Journal Article
- A1
- open access
COVID-19 and olfactory dysfunction : an ENT perspective to the current COVID-19 pandemic
-
- Conference Paper
- C3
- open access
Baseline characteristics of patients with chronic rhinosinusitis with nasal polyps and comorbid asthma from the pooled populations of the SINUS-24 and SINUS-52 Dupilumab phase 3 trials
-
Omalizumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps irrespective of asthma status
(2020) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 145(2). p.AB149-AB149 -
Omalizumab improves quality of life in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma
(2020) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. In Journal of Allergy and Clinical Immunology 145(2). p.AB250-AB250 -
Omalizumab responders analysis in nasal polyposis : a supplementary analysis of the co-primary endpoints of POLYP 1 and POLYP 2 trials
-
Relief of ocular symptoms in patients with house dust mite allergic rhinitis treated with the 300IR house dust mite SLIT tablet
-
The impact of nasal disorders on sleep
-
Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis
-
Dupilumab is associated with lower rates of respiratory infections in patients with chronic rhinosinusitis with nasal polyps-Safety analysis from the SINUS-52 phase 3 trial
-
Using virtual reality during immunotherapy in children : pilot study
-
Reduction in rescue medication use in patients treated with the 300IR house dust mite SLIT tablet
-
The importance of education on nasal spray and eye drop technique: Results from two community-pharmacy based studies
-
Anti-Bet v_1 MAB cocktail reduced birch allergic symptoms within one week, sustained over two months
(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 125(5). p.S19-S19 -
Anti-Bet v_1 MABs reduced basophil responsiveness to birch pollen stimulation ex-vivo in birch allergic patients
(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 125(5). p.S19-S19 -
Indirect treatment comparison of biologics used for the treatment of chronic rhinosinusitis with nasal polyps
(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 125(5). p.S48-S49 -
Continued safety / efficacy of omalizumab in chronic rhinosinusitis with nasal polyps : an open-label extension study
(2020) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 125(5). p.S15-S15 -
- Journal Article
- A1
- open access
Monoclonal antibodies and airway diseases
-
- Journal Article
- A1
- open access
Real-life assessment of chronic rhinosinusitis patients using mobile technology : the mySinusitisCoach project by EUFOREA
-
Clinical research needs for the management of chronic rhinosinusitis with nasal polyps in the new era of biologics : a National Institute of Allergy and Infectious Diseases workshop
-
- Journal Article
- A1
- open access
Allergic respiratory disease care in the COVID-19 era : a EUFOREA statement
-
- Journal Article
- A1
- open access
Efficacy and safety of omalizumab in nasal polyposis : 2 randomized phase 3 trials
-
- Journal Article
- A1
- open access
Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy
-
- Conference Paper
- C3
- open access
Using virtual reality during immunotherapy for children : pilot study
-
European position paper on rhinosinusitis and nasal polyps 2020
-
- Journal Article
- A1
- open access
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis : an EAACI position paper
-
Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP
-
Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis
-
A novel double-blind, placebo-controlled food challenge matrix for milk and raw egg
-
Rhinitis medication use in patients with persistent rhinitis: Belgian cross-sectional study with historical control
-
Efficacy of a 300IR house dust mite tablet is consistent when evaluated by the proportion of symptom-controlled days: Results of a large randomised, double-blind placebo-controlled, multicentre trial
-
Quality of life in patients with house dust mite-associated allergic rhinitis treated with 300IR house dust mite sublingual tablet : results of a large multicentre clinical trial
-
Efficacy and safety of the 300 IR sublingual tablet for the treatment of house dust mite-associated allergic rhinitis : a multicentre, international, dbpc, randomized phase III clinical trial
-
Mite immunotherapy with Alutard SQ 510 induces an incomplete protective antibody response
-
Severe asthma : entering an era of new concepts and emerging therapies : highlights of the 4th International Severe Asthma Forum, Madrid, 2018
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research : the European Strategic Forum on Allergic Diseases
-
Severe spontaneous epistaxis : retrospective study in a tertiary ENT centre
-
Much ado about biologicals : highlights of the Master Class on Biologicals, Prague, 2018
-
'Blockers' can benefit from 300IR house dust mite tablet-results of a large multicentre clinical trial in house dust mite induced allergic rhinitis patients
-
A prospective, feasibility study to evaluate the efficacy and usability of a novel drivable endoscope in patients with chronic rhinosinusitis
-
Omalizumab efficacy and safety in nasal polyposis : results from two parallel, double-blind, placebo-controlled trials
(2019) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. In Annals of Allergy Asthma & Immunology 123(5). p.S17-S17 -
Dupilumab improves patient-reported outcomes in chronic Rhinosinusitis with nasal polyps and comorbid asthma : sinus-24/sinus-52 trials
-
ARIA masterclass 2018 : from guidelines to real-life implementation
-
Baseline characteristics of phase 3 randomized controlled trials of omalizumab in chronic rhinosinusitis with nasal polyps
-
Real-life assessment of chronic rhinosinusitis patients using mobile technology
-
Immundefekte bei chronischer Rhinosinusitis : eine bedeutende und oft unterschätzte Ursache
-
EPOS2020 : development strategy and goals for the latest European Position Paper on Rhinosinusitis
-
- Journal Article
- A1
- open access
Twelve-year follow-up study after endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyposis
-
Endoscopic sinus surgery for type‐2 CRS wNP : an endotype‐based retrospective study
-
- Journal Article
- A1
- open access
Stepwise approach towards adoption of allergen immunotherapy for allergic rhinitis and asthma patients in daily practice in Belgium : a BelSACI-Abeforcal-EUFOREA statement
-
mySinusitisCoach : patient empowerment in chronic rhinosinusitis using mobile technology
-
Subtypisierung der Polyposis nasi : Phänotypen, Endotypen und Komorbiditäten
-
Atopic comorbidities and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) who failed intranasal corticosteroids
-
Emerging roles of innate lymphoid cells in inflammatory diseases : clinical implications
-
- Journal Article
- A1
- open access
Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels : a pilot study
-
EAACI position paper on the standardization of nasal allergen challenges
-
- Journal Article
- A1
- open access
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32
-
FcεRI expression and IgE binding by dendritic cells and basophils in allergic rhinitis and upon allergen immunotherapy
-
- Miscellaneous
- open access
What treatments are effective for common cold in adults and children?
-
- Journal Article
- A1
- open access
Development and validation of a standardized double-blind, placebo-controlled food challenge matrix for raw hazelnuts
-
Implementation of latex allergy clinical care pathways
-
Prospective study on the outcome of the sphenoid drill out procedure
-
- Conference Paper
- C3
- open access
Extent of sinus involvement in patients with bilateral nasal polyposis (NP) : baseline sinus ct scan results from a phase 2a study
-
Suppression of allergen-induced basophil activation upon treatment with subcutaneous house dust mite immunotherapy: a prospective study
-
Probiotics-impregnated bedding covers in house dust mite allergic rhinitis patients : a double-blind, randomised, placebo-controlled, crossover clinical trial
-
Dupilumab improves sense of smell and reduces anosmia among patients with nasal polyposis and chronic sinusitis : results from a phase 2a trial
-
A possible role of stem cells in nasal polyposis
-
The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps
-
Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps
-
Biotherapeutics in chronic rhinosinusitis with and without nasal polyps
-
EUFOREA Rhinology Research Forum 2016 : report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
-
Development of an LC-MS/MS method for the detection of traces of peanut allergens in chili pepper
-
IL-21 is increased in nasal polyposis and after stimulation with Staphylococcus aureus enterotoxin B
-
Reduced need for surgery in severe nasal polyposis with mepolizumab : randomized trial
-
Non-allergic rhinitis : position paper of the European Academy of Allergy and Clinical Immunology
-
- Journal Article
- A1
- open access
Multi-morbidities of allergic rhinitis in adults : European Academy of Allergy and Clinical Immunology Task Force report
-
Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance
-
- Journal Article
- A1
- open access
Probiotics-impregnated bedding covers for house dust mite allergic rhinitis : a pilot randomized clinical trial
-
Reliable mite-specific IgE testing in nasal secretions by means of allergen microarray
-
Alcohol hyper-responsiveness in chronic rhinosinusitis with nasal polyps
-
Chronic rhinosinusitis without nasal polyps
-
Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis
-
Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis : a randomized clinical trial
-
The quest for autoreactive antibodies in nasal polyps
-
The response to nasal allergen provocation with grass pollen is reduced in patients with chronic rhinosinusitis with nasal polyposis and grass sensitization
-
Nasal immunity, rhinitis, rhinosinustis
-
Immunological characterization of pediatric liver transplant associated food allergy
-
Comparison of different medical treatment options for CRSwNP : doxycycline, methylprednisolone, mepolizumab and omalizumab
-
Use of filter disks or sinus packs for single and repeated measurement of total and house dust mite specific IgE in nasal secretions
-
Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis
-
Allergic sensitization, high local IL-5 and IgE predict surgical outcome 12 years after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis
-
Latexallergie: preventie voor patiënt en personeel
-
Local IgE in non-allergic rhinitis
-
In vivo diagnosis of allergic diseases-allergen provocation tests
-
Raised immunoglobulin A and circulating T follicular helper cells are linked to the development of food allergy in pediatric liver transplant patients
-
- Journal Article
- A1
- open access
Raised immunoglobulin A and circulating T follicular helper cells are linked to the development of food allergy in paediatric liver transplant patients
-
Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells
-
- Journal Article
- A1
- open access
Local immunoglobulin E in the nasal mucosa : clinical implications
-
No evidence of autoreactivity in nasal polyposis
-
Use of paper filter discs for measurement of local biomarkers of nasal mucosal inflammation
-
Self-medication in persistent rhinitis: overuse of decongestants in half of the patients
-
Self-medication in persistent rhinitis: overuse of decongestants in half of the patients
-
Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps
-
The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis : a 3-year prospective observational study
-
Vascular endothelial growth factor receptor 1 expression in nasal polyp tissue
-
Nasal allergen provocation test in nasal polyposis with and without allergy
-
Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?
-
Dissemination and implementation of the ARIA guidelines for allergic rhinitis in general practice
-
Should clinicians use omalizumab for the treatment of nasal polyps?: reply
-
- Conference Paper
- C3
- open access
The importance of local eosinophilia in the surgical outcome of chronic rhinosinusitis : a 3-year prospective observational study
-
Post-transplant food allergy in children is associated with liver and not with renal transplantation: a monocentric comparative study
-
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
-
Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Prevalence of allergic sensitization versus allergic rhinitis symptoms in an unselected population
-
Executive summary of European Task Force document on diagnostic tools in rhinology
-
IL-21 is increased in nasal polyposis and after stimulation with Staphylococus aureus enterotoxins
-
Chronic rhinosinusitis: from one disease to different phenotypes
-
Local free light chain expression is increased in chronic rhinosinusitis with nasal polyps
-
Local inflammation in chronic upper airway disease
-
EPOS 2012 : European position paper on rhinosinusitis and nasal polyps 2012 : a summary for otorhinolaryngologists
-
European position paper on rhinosinusitis and nasal polyps 2012
-
Rhinosinusitis and asthma
-
Omalizumab is effective in allergic and non-allergic patients with nasal polyps and asthma
-
The who, where, and when of IgE in allergic airway disease
-
Inflammation and remodelling patterns in early stage chronic rhinosinusitis
-
- Journal Article
- A2
- open access
Diagnostic tools in Rhinology EAACI position paper
-
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
-
Pathogenesis of chronic rhinosinusitis: inflammation
-
Nasal secretion assays predict superantigen involvement in nasal polyposis
-
European view on the pathology of chronic rhinosinusitis, nasal polyposis and the impact of staphylococcal enterotoxins: first results of the Ga2len sinusitis cohort study
-
- Conference Paper
- C3
- open access
Staphylococcal enterotoxin specific IgE in serum is linked to severe asthma and nasal polyposis
-
- Conference Paper
- C3
- open access
European view on the pathology of chronic rhinosinusitis, nasal polyposis and the impact of staphylococcal enterotoxins: first results of the Ga2len sinusitis cohort study
-
Mucosal tissue polyclonal IgE is functional in response to allergen and SEB
-
Pathophysiology of chronic rhinosinusitis
-
- Conference Paper
- C3
- open access
The prevalence of sensitization and relevant symptoms of allergic rhinitis in an unselected Belgium population
-
Increased serum-soluble interleukin-5 receptor alpha level precedes the development of eczema in children
-
Staphylococcus aureus enterotoxin B facilitates allergic sensitization in experimental asthma
-
Oral steroids and doxycycline: Two different approaches to treat nasal polyps
-
- Book Chapter
- open access
Staphylococcus aureus-derived superantigens in nasal polyp disease
-
Nasal polyposis and sinusitis
-
Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GA(2)LEN study
-
Efficacy of allergoid preparations for subcutaneous application - Evaluation of evidence in clinical studies
-
- Journal Article
- A1
- open access
Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue
-
TGF-beta signaling and collagen deposition in chronic rhinosinusitis
-
Local Complement Activation in Nasal Polyposis
-
Role of Staphylococcus Aureus Enterotoxin B in allergic sensitization
-
Chronic rhinosinusitis with and without nasal polyps: what is the difference?
-
Decreased FOXP3 protein expression in patients with asthma
-
- Journal Article
- A1
- open access
Differential expression of the interleukin 5 receptor alpha isoforms in blood and tissue eosinophils of nasal polyp patients
-
Treatment of nasal polyposis with oral methylprednisolone: a double-blind, randomized, placebo-controlled trial with evaluation of clinical and biological activity
-
TGF-beta isoforms and receptors in chronic sinus disease
-
Role of staphylococcal superantigens in upper airway disease
-
Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps
-
T-cell regulation in chronic paranasal sinus disease
-
Detection of enterotoxin DNA in Staphylococcus aureus strains obtained from the middle meatus in controls and nasal polyp patients
-
Staphylococcus aureus Enterotoxin B breaks primary tolerance to ovalbumine
-
Mepolizumab, a humanised anti-IL-5 monoclonal antibody, as treatment of severe nasal polyposis
-
Staphylococcus Aureus Enterotoxins as Immune Stimulants in Chronic Rhinosinusitis
-
Role of Staphylococcal superantigens in airway disease
-
T cell regulation in chronic sinus disease
-
Staphylococcus aureus sensitization and allergic disease in early childhood: Population-based birth cohort study
-
Upper airway inflammation in chronic smoke exposed mice
-
Preclinical study of a novel, non-steroidal, plant-derived, anti-inflammatory compound for the treatment of airway disease
-
Role of staphylococcal superantigens in airway disease: a review, part 2: S-aureus enterotoxins in AERD, asthma, early childhood wheezing and COPD
-
Local immunoglobulin production in nasal polyposis is modulated by superantigens
-
Staphylococcus aureus enterotoxin B stimulation in nasal polyps
-
Remodelling in nasal polyposis is independent of TH-cell polarisation
-
Staphylococcal superantigens in airway disease: a review, part 1: the role of S-aureus enterotoxins in allergic rhinitis and nasal polyps
-
Development of a rabbit model to study inflammation in nasal and paranasal cavities
-
Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps
-
Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B
-
Differentiation of chronic sinus diseases by measurement of inflammatory mediators
-
New insights into the pathology of nasal polyposis: the role of superantigens and IgE
-
An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis
-
Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators
-
Pharmacological management of nasal polyposis
-
Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue
-
Allergic rhinitis, rhinosinusitis, and asthma : one airway disease
-
- PhD Thesis
- open access
EOSINOPHILIC INFLAMMATION IN NASAL POLYPOSIS: REGULATION OF INTERLEUKIN 5 AND INTERLEUKIN 5 RECEPTOR α ISOFORMS
(2004) -
Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: Studies on the relationship
-
Macrophage mannose receptor in chronic sinus disease
-
Transforming growth factor β1 in nasal remodeling : differences between chronic rhinosinusitis and nasal polyposis
-
Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis
-
Increased IgE-antibodies to Staphylococcus aureus enterotoxins in patients with COPD
-
Collection of nasal secretions for immunological analysis
-
Soluble interleukin-5 receptor alpha is increased in acute exacerbation of chronic obstructive pulmonary disease
-
Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor α-chain expression by cytokines : IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor α expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor α expression
-
IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma
-
Superantigens and nasal polyps
-
Human beta-defensins and toll-like receptors in the upper airway
-
Interleukin 5, eosinophilic diseases and therapeutic intervention
-
Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis
-
- Journal Article
- A1
- open access
Quantitative real time polymerase chain reaction for measurement of human interleukin-5 receptor alpha spliced isoforms mRNA
-
Expression of TGF-beta 1, -beta 2, EGF and PDGF in nasal secretions after sinus surgery
-
Quantification of soluble and membrane anchored isoforms of IL-5R alpha using real-time PCR
-
Staphylococcus aureus superantigens and airway disease.
-
Mediators in nasal polyposis.
-
Staphylococcus aureus enterotoxins: a key in airway disease?
-
Up-regulation of IL-18 in allergic rhinitis.
-
Wound healing of the nasal and paranasal mucosa: A review.
-
Secretion of TGF-beta 1, TGF-beta 2, EGF and PDGF into nasal fluid after sinus surgery.
-
Expression of TGF-beta 1,-beta 2, EGF and PDGF in nasal secretions after sinus surgery
-
Nasal polyposis: Is there a link between eosinophils and IgE?
-
Total and specific IgE in nasal polyps is related to local eosinophilic inflammation.
-
Nasal polyposis: From cytokines to growth.
-
Effect of intranasal corticosteroids on release of cytokines and inflammatory mediators
-
Nasal polyposis - A new concept on the formation of polyps.
-
Cytokines and nasal polyposis.